FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression
Yahoo Finance - WILMINGTON, Del., Oct. 20 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN - News ) today announced that the U.S. Food and Drug Administration (FDA) has approved SEROQUEL® (quetiapine fumarate) for the treatment of patients with depressive episodes
Source: biz.yahoo.comTreatment-Resistant Depression: Diagnostic Strategies and Current Medscape News - Misdiagnosis also includes failure to identify the actual subtype of mood disorder, which is common, as is ruling out a diagnosis of atypical, psychotic, or bipolar depression. All of these considerations have an impact on treatment selection. In
Source: www.medscape.comThe Treatment of Elderly Patients With Bipolar Disorder CME/CE Medscape News - Lamotrigine use in geriatric patients with bipolar depression. Can J Psychiatry. 2002;47:767-770. Abstract Sajatovic M, Gyulai L, Calabrese JR, et al. Maintenance treatment outcomes in older patients with bipolar I disorder. Am J Geriatr Psychiatry
Source: www.medscape.comU.S. Clears Seroquel for Bipolar DepressionMedscape News - LONDON (Reuters) Oct 20 - AstraZeneca Plc said on Friday it had won U.S. approval for Seroquel (quetiapine) to be sold as treatment for bipolar depression. The antipsychotic drug had already been cleared by the Food and Drug Administration as a
Source: www.medscape.comHappy event? When motherhood hurtsHealth 24 - The three most common diagnoses are unipolar depression, bipolar depression and schizophrenia. Treatment usually requires hospitalization and medication. The prognosis is generally good, and Postnatal Psychosis appears to respond well to anti
Source: www.health24.com Click here for more information about women and depression
women and depression